ketorolac tromethamine · Abbvie · NDA 022427
Acuvail
Earliest generic entry, as listed
15 Aug 2029
Blocked by patent: US 7842714.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7842714 | substance, product | 15 Aug 2029 |
| US 8512717 | product | 7 Mar 2028 |
| US 9192571 | product | 7 Mar 2028 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022427 · 001 · RLD | solution/drops, ophthalmic | 0.45% | 15 Aug 2029 |